SAFETY INFORMATION

AREXVY is a vaccine that helps to protect adults 60 years of age and older from lower lung disease caused by respiratory syncytial virus (RSV). 100% protection cannot be guaranteed. AREXVY is not indicated for the treatment of RSV and does not prevent or reduce the risk of complications. AREXVY should not be used if you are allergic to any ingredient in the vaccine. Adverse events may occur. Very common adverse events (≥10% of doses) reported in clinical trials were pain at the injection site, tiredness, headache, muscle pain (myalgia), and joint pain (arthralgia). Ask your healthcare professional if AREXVY is right for you. Full product information can be found at gsk.ca/arexvy/en. To report an adverse event, please call 1-800-387-7374.